Financial Engines Advisors L.L.C. Pfizer Inc Transaction History

Financial Engines Advisors L.L.C.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $162,580 - $211,174	6,222 Added 84.4%	13,594 $391,000
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $236,567 - $276,523	7,372 New	7,372 $244,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $35,805 - $46,613	-909 Reduced 14.64%	5,301 $216,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $149,673 - $195,382	-3,585 Reduced 36.6%	6,210 $318,000
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $79,249 - $96,743	1,811 Added 22.68%	9,795 $428,000
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $371,495 - $440,477	7,984 New	7,984 $418,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $230,580 - $285,717	-5,040 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $290,231 - $430,220	-7,024 Reduced 58.22%	5,040 $298,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $1,923 - $2,470	49 Added 0.41%	12,064 $518,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $74,836 - $84,777	-2,084 Reduced 14.78%	12,015 $471,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $24,213 - $27,307	723 Added 5.41%	14,099 $511,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $692,996 - $881,204	-20,705 Reduced 60.75%	13,376 $492,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $869,092 - $1.02 Million	27,373 Added 408.06%	34,081 $1.25 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $202,044 - $245,110	6,708 New	6,708 $219,000
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $11,359 - $13,179	-356 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $11,840 - $12,563	356	356 $13,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.